Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-03-25

FDA Approved: OLANZAPINE AND FLUOXETINE — Original Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approves Teva's olanzapine and fluoxetine combination as an original ANDA generic product for depressive episodes in bipolar I disorder and for treatment-re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Olanzapine and fluoxetine (olanzapine; fluoxetine)

Snippet

ORIG AP for OLANZAPINE AND FLUOXETINE (OLANZAPINE AND FLUOXETINE)